Simplex Trading
ROIV icon

Simplex Trading’s Roivant Sciences ROIV Stock Holding History

Simplex Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-88,035
Closed -$2.6M – 10151
2026
Q1 		$2.44M Sell
88,035
-55,862
-39% -$1.44M ﹤0.01% 1667
2025
Q4 		$3.12M Buy
143,897
+98,669
+218% +$1.95M ﹤0.01% 1624
2025
Q3 		$684K Buy
45,228
+1,972
+5% +$24.4K ﹤0.01% 3459
2025
Q2 		$487K Sell
43,256
-72,948
-63% -$791K ﹤0.01% 3536
2025
Q1 		$1.17M Buy
+116,204
New +$1.26M ﹤0.01% 2545
2024
Q4 		– Sell
-37,475
Closed -$443K – 9468
2024
Q3 		$432K Buy
+37,475
New +$427K ﹤0.01% 3754
2024
Q2 		– Sell
-54,030
Closed -$592K – 9651
2024
Q1 		$569K Sell
54,030
-64,684
-54% -$697K ﹤0.01% 3726
2023
Q4 		$1.33M Buy
118,714
+116,009
+4,289% +$1.13M ﹤0.01% 2739
2023
Q3 		$31K Buy
+2,705
New +$30.6K ﹤0.01% 6231
2022
Q4 		– Sell
-15,890
Closed -$88.4K – 10228
2022
Q3 		$51K Sell
15,890
-24,064
-60% -$93.2K ﹤0.01% 6424
2022
Q2 		$162K Buy
39,954
+29,432
+280% +$117K ﹤0.01% 4898
2022
Q1 		$51K Buy
+10,522
New +$69.4K ﹤0.01% 7107

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Simplex Trading's ROIV Position: Q2 2026 in Review

Simplex Trading sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 88,035 shares — an estimated $2.6M sold.

Simplex Trading first reported a position in ROIV in Q1 2022 and held it in 12 quarters. The position peaked at $3.12M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Simplex Trading reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 88,035 Roivant Sciences shares in Q2 2026, an estimated $2.6M.
  • Simplex Trading first reported a position in Roivant Sciences in Q1 2022 and held it in 12 quarters.
  • Simplex Trading's Roivant Sciences position peaked at $3.12M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.